Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer
D Sanjanwala, V Patravale - Drug Discovery Today, 2023 - Elsevier
Highlights•Active targeting uses ligands to target drugs to particular tissues or
cells.•Antibodies are commonly used targeting ligands which are bulky and difficult to …
cells.•Antibodies are commonly used targeting ligands which are bulky and difficult to …
In silico Study of Alkaloid Compounds with Computational Approach for Selection of Drug Leads for COVID-19
SA Victoria, IT Pramanda, AA Parikesit - Coronaviruses, 2023 - ingentaconnect.com
Background: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the virulent source of COVID-19 disease. As a result of the rapid transmission of the viral …
the virulent source of COVID-19 disease. As a result of the rapid transmission of the viral …